Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Trinucleotide repeat expansion and RNA dysregulation in fragile X syndrome: emerging therapeutic approaches

RNA(2024)10.1261/rna.080270.124Source: DataRank Database

Trinucleotide repeat expansion and RNA dysregulation in fragile X syndrome: emerging therapeutic approaches is a research paper published in RNA (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.78)OA: bronzeTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Joel D. Richter ORCID,Suna Jung ORCID

Live enrichment

PubMed:39725461 PMC:PMC11874960 OpenAlex:https://openalex.org/W4405803047

NIGMS NIH HHS

Grant: R35 GM149216

NINDS NIH HHS

Grant: R01 NS132935

National Institutes of Health

Grant: 5R35GM149216-02

RNA Control of Neural Function

National Institutes of Health

Grant: 5R01NS132935-03

Therapeutic Potential of Rescued FMR1 Mis-Splicing in Fragile X Syndrome

FWCI

0.78

Citation Percentile

0.8%

Citation Trend

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc/4.0/This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/ (http://creativecommons.org/licenses/by-nc/4.0/) .

journalhttp://rnajournal.cshlp.org/content/early/2024/12/26/rna.080270.124.full.pdf

publisherhttp://rnajournal.cshlp.org/content/early/2024/12/26/rna.080270.124.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1261/rna.080270.124

journalhttps://doi.org/10.1261/rna.080270.124

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39725461

Fields of Study

Genetics and Neurodevelopmental DisordersRNA modifications and cancerRNA Research and Splicing0301 basic medicine0303 health sciences03 medical and health sciencesFragile X SyndromeHumansTrinucleotide Repeat ExpansionFragile X Messenger Ribonucleoprotein 1AnimalsRNA SplicingOligonucleotides, AntisenseMice

MeSH Terms

AnimalsFragile X SyndromeHumansRNA SplicingRNA, MessengerOligonucleotides, AntisenseDNA MethylationTrinucleotide Repeat ExpansionMiceFragile X Messenger Ribonucleoprotein 1Fragile X Mental Retardation Protein

Keywords

BiologyFMR1Trinucleotide repeat expansionFragile X syndromeRNA splicingGeneticsAlternative splicingGene silencingGeneTranslation (biology)RNACell biologyMessenger RNAFragile xAlleleR-loopRepeat ExpansionSplicing DysregulationMiceFragile X Messenger Ribonucleoprotein 1PerspectiveHumansAnimalsOligonucleotides, Antisense

Sustainable Development Goals

SDG 0: Good health and well-being